Figure 1 | Scientific Reports

Figure 1

From: Contribution of the uremic milieu to an increased pro-inflammatory monocytic phenotype in chronic kidney disease

Figure 1

Monocyte subpopulations in CKD patients versus healthy control (Ctrl). CKD: patients with chronic kidney disease stages 1 to 5; HD: hemodialysis patients; PD: peritoneal dialysis patients. Results are presented a mean ± SD. One significance symbol: p < 0.05, two symbols: p < 0.01; * vs. Ctrl; ° vs. CKD; § vs. HD. CD14++CD16−: classical monocytes; CD14++CD16+: intermediate monocytes; CD14+CD16++: non classical monocytes.

Back to article page